Zila to Present at the 20th Annual Roth Capital Partners Growth Stock Conference
February 15 2008 - 8:00AM
Business Wire
Zila, Inc. (NASDAQ:ZILA) today announced that Frank J. Bellizzi,
DMD, president of Zila Pharmaceuticals, will present a company
overview at the 20th Annual Roth Capital Partners Growth Stock
Conference on Tuesday, February 19 at 4:00 p.m. Pacific Time at The
Ritz-Carlton in Laguna Niguel, California. Interested parties may
listen to the webcast of this presentation by visiting the
company�s website at www.zila.com. Listeners are encouraged to
visit the website at least 15 minutes prior to the start of the
scheduled presentation to register, download and install any
necessary audio software. For those unable to listen to the live
webcast, the presentation will be archived on the same Web site for
30 days. About Zila: Zila is a fully integrated oral diagnostic
company dedicated to the prevention, detection and treatment of
oral disease, with a primary focus on oral cancer. ViziLite� Plus,
the company's flagship product for the early detection of oral
abnormalities that could lead to cancer, is the first and only
adjunctive medical device cleared by the FDA for use in a
population at increased risk for oral cancer. In addition, Zila
designs, manufactures and markets a suite of proprietary products
sold exclusively and directly to dental professionals for
periodontal disease, including the Rota-dent(R) Professional
Powered Brush, the Pro-Select(R) Platinum ultrasonic scaler and a
portfolio of oral pharmaceutical products for both in-office and
home-care use. For more information about the company and its
products, please visit www.zila.com.
Zila (NASDAQ:ZILA)
Historical Stock Chart
From May 2024 to Jun 2024
Zila (NASDAQ:ZILA)
Historical Stock Chart
From Jun 2023 to Jun 2024